Previous research has demonstrated that RFC3 is markedly overexpressed in various malignant tumors, RFC3 demonstrates elevated expression levels in head and neck squamous cell carcinoma (HNSCC), correlating with tumor progression, reduced survival rates, and the infiltration of immune cells. The gene discussed is RFC3; the disease is cancer.